Skip to main content
. Author manuscript; available in PMC: 2023 Jul 4.
Published in final edited form as: Mol Pharm. 2022 Apr 29;19(7):2535–2541. doi: 10.1021/acs.molpharmaceut.2c00211

Figure 3.

Figure 3.

Representative maximum intensity projection (MIP) and coronal PET images of 64Cu-NOTA-PEG2Nle-CycMSHhex on a B16/F10 melanoma-bearing C57 mouse at 2 h post-injection. The melanoma lesions (T) are highlighted with arrows on the images.